The overall aim in this "proof-of-concept" study is to evaluate if a diet concept, based on foods that have individually been reported to beneficially affect gut microbiota in fact has an effect on gut microbiota composition and activity among healthy and obese subjects and whether the effects are associated with altered cardiometabolic risk factors. The aim is further to investigate if such alterations are reflected in changes of the fecal and plasma metabolome. In total, 40 men and women, who meet all the inclusion criteria and none of the exclusion criteria will be invited to participate in the study. The participants will follow an intervention diet for 6 weeks and a control diet for 6 weeks, with a 6-week wash-out period in between and will be randomized to either begin with the intervention diet or the control diet. The study will be running over 18 weeks (including a 6-week wash-out period) and it will include 9 visits at the clinic.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
40
A review has been undertaken to both identify specific bacteria associated with cardiometabolic risk factors and food items that have been shown to affect such bacteria in a beneficial direction. The intervention diet will include a variety of food items e.g. vegetables, fermented vegetables, fermented dairy products and cereal products. The control diet is based on a Swedish Average Diet
University of Gothenburg, Department of Food and Nutrition and Sport Science
Gothenburg, Sweden
Gut microbiome
Fecal samples will analyzed for composition of the gut microbiome. Difference in gut microbiota OTUs between the two diets. Baseline compared with after 6 weeks of intervention or control.
Time frame: 6 weeks
Gut microbiome
Fecal samples will analyzed for composition of the gut microbiome. Change in gut microbiota OTUs between baseline and 6 and 18 weeks of intervention or control.
Time frame: 6 weeks, 18 weeks
Triglycerides
Investigate if fasting plasma triglycerides differ between control and intervention.
Time frame: 3 weeks, 6 weeks, 12 weeks and 18 weeks
Cholesterol
Investigate if fasting plasma cholesterol differ between control and intervention.
Time frame: 3 weeks, 6 weeks, 12 weeks and 18 weeks
Low-density lipid protein
Investigate if fasting plasma Low-density lipid proteindiffer between control and intervention.
Time frame: 3 weeks, 6 weeks, 12 weeks and 18 weeks
High-density lipid protein
Investigate if fasting plasma High-density lipid protein differ between control and intervention.
Time frame: 3 weeks, 6 weeks, 12 weeks and 18 weeks
Blood pressure
Investigate if fasting blood pressure differ between control and intervention.
Time frame: 3 weeks, 6 weeks, 12 weeks and 18 weeks
Fasting glucose
Investigate if fasting plasma glucose differ between control and intervention.
Time frame: 3 weeks, 6 weeks, 12 weeks and 18 weeks
C-reactive protein
Investigate if fasting plasma C-reactive protein differ between control and intervention.
Time frame: 3 weeks, 6 weeks, 12 weeks and 18 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.